PG

Procter & Gamble Company
D

PG

Arincen73/100B

Procter & Gamble Company balance sheet 1986–2027

Procter & Gamble Company had 15.37B USD in cash and short-term investments on 30 September 2026, against total debt of 38.93B USD: net debt of 23.56B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q1 FY2027
FY2026
30 Jun 2026
FY2025
30 Jun 2025
FY2024
30 Jun 2024
FY2023
30 Jun 2023
FY2022
30 Jun 2022
FY2021
30 Jun 2021
FY2020
30 Jun 2020
FY2019
30 Jun 2019
FY2018
30 Jun 2018
FY2017
30 Jun 2017
Cash and equivalents
15.37B9.94B9.56B9.48B8.25B7.21B10.29B16.18B4.24B2.57B5.57B
Short-term investments
0.000.000.000.000.000.000.000.006.05B9.28B9.57B
15.37B9.94B9.56B9.48B8.25B7.21B10.29B16.18B10.29B11.85B15.14B
Cash growth
+37.54%+4.04%+0.78%+14.99%+14.31%-29.88%-36.42%+57.30%-13.19%-21.72%+13.40%
Receivables
6.62B6.06B6.19B6.12B5.47B5.14B4.73B4.18B4.95B4.69B4.59B
Inventory
8.49B8.17B7.55B7.02B7.07B6.92B5.98B5.50B5.02B4.74B4.62B
Other current assets
2.04B2.04B2.10B2.09B1.86B2.37B0.002.13B2.22B2.05B2.14B
Total current assets
32.51B26.21B25.39B24.71B22.65B21.65B23.09B27.99B22.47B23.32B26.49B
Property, plant and equipment
25.52B25.36B23.90B22.15B21.91B21.20B21.69B20.69B21.27B20.60B19.89B
Long-term investments
0.000.000.000.000.00140.00M192.00M0.000.000.000.00
Goodwill and intangibles
62.56B62.72B63.56B62.35B64.44B63.38B64.57B63.69B64.49B69.08B68.89B
Goodwill
41.20B41.28B41.65B40.30B40.66B39.70B40.92B39.90B40.27B45.18B44.70B
Intangible assets
21.36B21.44B21.91B22.05B23.78B23.68B23.64B23.79B24.22B23.90B24.19B
Other non-current assets
12.55B12.23B12.38B13.16B11.83B10.84B9.77B8.33B6.86B5.31B5.13B
Total assets
133.13B126.52B125.23B122.37B120.83B117.21B119.31B120.70B115.10B118.31B120.41B
Accounts payable
17.06B16.31B15.23B15.36B14.60B14.88B13.72B12.07B11.26B10.34B9.63B
Deferred revenue
0.000.000.000.000.000.000.000.000.000.000.00
Short-term debt
17.03B11.30B9.51B7.19B10.23B8.65B8.89B11.18B9.70B10.42B13.55B
Other current liabilities
1.00M5.63B5.74B5.33B5.75B4.88B5.53B5.26B4.41B3.97B3.60B
Total current liabilities
45.00B38.69B36.06B33.63B35.76B33.08B33.13B32.98B30.01B28.24B30.21B
Long-term debt
21.90B22.84B25.00B25.27B24.38B22.85B23.10B23.54B20.40B20.86B18.04B
Other non-current liabilities
4.95B4.27B5.42B5.73B6.56B7.02B9.64B10.46B10.21B10.08B8.22B
Lease obligations, current
0.00246.00M255.00M243.00M222.00M205.00M219.00M239.00M9.00M22.00M13.00M
Lease obligations, long-term
0.00641.00M701.00M666.00M595.00M595.00M631.00M652.00M0.0085.00M38.00M
Total liabilities
77.80B72.21B72.95B71.81B73.76B70.35B72.65B73.82B67.52B65.43B64.63B
Common stock and paid-in capital
0.004.01B4.01B4.01B4.01B4.01B4.01B4.01B4.01B4.01B4.01B
Retained earnings
138.02B135.85B129.97B123.81B118.17B112.43B106.37B100.24B94.92B98.64B96.12B
Accumulated other comprehensive income
-12.65B-12.47B-12.14B-11.90B-12.22B-12.19B-13.74B-16.17B-14.94B-14.75B-14.63B
Shareholders' equity
55.10B54.31B52.01B50.29B46.78B46.59B46.38B46.52B47.19B52.29B55.18B
Minority interest
239.00M230.00M272.00M272.00M288.00M265.00M276.00M357.00M385.00M590.00M594.00M
38.93B35.03B35.46B33.37B35.42B32.29B32.84B35.61B30.10B31.39B31.64B
Net cash
-23.56B-25.08B-25.91B-23.89B-27.18B-25.08B-22.55B-19.43B-19.81B-19.54B-16.51B
Working capital
-12.49B-12.49B-10.67B-8.92B-13.11B-11.43B-10.04B-4.99B-7.54B-4.92B-3.72B
Book value per share
22.8922.4221.1920.3418.8318.3517.8317.7218.5819.6820.14
Tangible book value
-7.46B-8.41B-11.55B-12.06B-17.67B-16.79B-18.19B-17.17B-17.29B-16.78B-13.70B
Tangible book value per share
-3.10-3.47-4.71-4.88-7.11-6.61-6.99-6.54-6.81-6.32-5.00
Current ratio
0.720.680.700.730.630.650.700.850.750.830.88
Debt to equity
0.710.640.680.660.760.690.710.770.640.600.57

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about Procter & Gamble Company's cash and debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.